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Background: Osteoradionecrosis (ORN) is a critical complication after carbon ion (C-ion) or photon radiotherapy (RT)
for head and neck tumors. However, the risk factors for ORN after C-ion RT remain unclear. Therefore, the present study
aimed to investigate the effects of the dose-volume relationship on and risk factors for ORN development after C-ion
RT. We, however, focused on the maxillary bone because most tumors treated with C-ion RT were primarily located in
the sinonasal cavity.
Methods: The patients enrolled in this study received more than 10% of the prescribed total dose of 57.6 Gy
equivalent (GyE) in 16 fractions to their maxilla. All patients were followed up for more than 2 years after C-ion RT.
Those with tumor invasion to the maxilla before C-ion RT or local recurrence after the treatment were excluded from
the study to accurately evaluate the effects of irradiation on the bone. Sixty-three patients were finally selected. The
severity of ORN was assessed according to the Common Terminology Criteria for Adverse Events version 4.0. The
correlation between clinical and dosimetric parameters and ORN incidence was retrospectively analyzed.
Results: The median follow-up period was 79 months. Of the 63 enrolled patients, 26 developed ORN of grade ≥1.
Multivariate analysis revealed that the maxilla volume receiving more than 50 GyE (V50) and the presence of teeth
within the planning target volume were significant risk factors for ORN. Dose-volume histogram analysis revealed that
V10 to V50 parameters were significantly higher in patients with ORN than in those without ORN.
Conclusions: V50 and the presence of teeth within the planning target volume were independent risk factors for the
development of ORN after C-ion RT using a 16-fraction protocol.
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Carbon ion radiotherapy (C-ion RT) offers a potential cure
for radio-resistant tumors owing to its increased biologic
potential and improved dose localization properties.
In a recent report, we demonstrated that C-ion RT
was a promising treatment option for various inoperable
and radio-resistant tumors [1].
In addition, we have published the results of a
phase II clinical trial of C-ion RT in patients with head
and neck tumors [2]. In this trial, C-ion RT demonstrated* Correspondence: koto@nirs.go.jp
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unless otherwise stated.excellent disease control in radio-resistant tumors such as
mucosal malignant melanoma, adenoid cystic carcinoma,
and adenocarcinoma. However, the development of osteor-
adionecrosis (ORN) remained one of the serious complica-
tions after C-ion RT.
ORN is a well-documented complication of photon
RT for head and neck tumors. The degree of ORN varies
from limited, asymptomatic bone exposures that may
remain stable for a prolonged period of time or heal with
conservative management, to severe necroses necessitating
surgical intervention and reconstruction [3]. Thus, ORN is
a serious clinical problem. Several clinical risk factors for
ORN such as smoking, drinking, oral hygiene, and tumor
characteristics have been implicated in the literature [3-5].al Ltd. This is an Open Access article distributed under the terms of the Creative
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parameter has been also known to be a major contributor
to ORN [4,6-9]. However, there remains a lack of data on
ORN after C-ion RT.
The present study aimed to investigate the effects of
the dose-volume relationship on and risk factors for
ORN development after C-ion RT. We, however, focused
on the maxillary bone in this investigation because most
tumors treated with C-ion RT were located in the
sinonasal cavity.
Methods
Patients and tumor characteristics
From April 1997 to February 2006, a total of 236
patients with head and neck tumors were treated with
C-ion RT in a phase II clinical trial at our institution [2].
Of these, patients who received more than 10% of a pre-
scribed total dose of 57.6 gray equivalent (GyE) in 16
fractions to the maxilla and were followed up for more
than 2 years after C-ion RT were selected. Those with
tumor invasion to the maxilla before C-ion RT or local
recurrence after treatment were excluded from the study
to accurately evaluate the effects of irradiation on the
maxilla. Based on results from a previous clinical trial
[10], a total dose of 57.6 GyE or 64.0 GyE in 16 fractions
was prescribed for head and neck tumors. However, only
patients treated with 57.6 GyE were included in the present
study as a homogeneous population for analysis. Sixty-three
patients were finally included in our study cohort.
Before C-ion RT, all patients provided written informed
consent acknowledging the possibility of ORN as a
result of the treatment. The study was approved by
the institutional ethics committee (National Institute
of Radiological Sciences).
The median age of the 63 enrolled patients (32
men and 31 women) was 59 years (range, 16–80 years).
Of these, 22 smoked and 31 consumed alcohol. The pres-
ence of teeth within the planning target volume (PTV)
was documented in 29 patients. Histological classification
of all patients’ tumors included 24 patients of malignant
melanoma, 24 adenoid cystic carcinomas, 9 adenocarcin-
omas, 2 squamous cell carcinomas, 2 mucoepidermoid
carcinomas, and 1 each of epithelial/myoepithelial car-
cinoma and undifferentiated carcinoma. Eighteen of
the studied tumors were located in the paranasal
sinus, 17 in the nasal cavity, 12 on the parotid gland,
6 in the oral cavity, and 10 at other sites. All patients
underwent dental examination and management before
C-ion RT. If dental extraction was necessary, C-ion RT
was performed at least 10 days after such procedure. Of
the 23 patients who received adjuvant or neo-adjuvant
chemotherapy, 18 had malignant mucosal melanoma and
received combinatorial chemotherapy with dacarbazine,
nimustine, and vincristine.C-ion RT
For C-ion RT, each patient was positioned in customized
cradles (Moldcare; Alcare, Tokyo, Japan) and immobilized
with a low-temperature thermoplastic device (Shellfitter;
Kuraray, Osaka, Japan). A set of computed tomography
(CT) images at 2.5-mm slide thickness was obtained for
treatment planning using the immobilization devices.
Three-dimensional treatment planning was performed
with HIPLAN software [11].
The clinical target volume had a minimum margin of
5 mm added to the gross tumor volume. Furthermore, a
margin of 3–5 mm was added as an internal and setup
margin around the clinical target volume to create a
final PTV. In principle, more than 3 portals were used
to improve dose distribution.
During each treatment session, the patient’s position
was verified with a computer-aided online positioning
system. The patient was positioned on the treatment
couch using immobilization devices, and then digital
orthogonal radiographic images were taken and transferred
to the positioning computer. The positioning images were
compared with the reference images digitally reconstructed
from CT scans. If the difference in positioning was more
than 2 mm, the treatment couch was repositioned until
appropriate.
The carbon beam dose was expressed in terms of pho-
ton equivalent dose, defined as the physical dose multi-
plied by the relative biological effectiveness (RBE) of
carbon ions. The clinical RBE of the carbon beam at our
institute was determined according to the RBE for acute
skin reaction, which was 3.0 at the distal part of the
spread-out Bragg peak [12]. C-ion RT was delivered in 16
fractions over a 4-week period with 4 treatment days per
week. The prescribed total dose was 57.6 GyE in all
patients. C-ion RT was performed without concurrent
chemotherapy in all patients.
Follow-up and ORN evaluation
After C-ion RT, patients were followed up every 2 to
3 months during the first 2 years and every 3 to 6
months thereafter. Magnetic resonance imaging (MRI)
examination of the head and neck region was performed
at 4–6-month intervals. A diagnosis of maxillary ORN
was indicated on the basis of clinical symptoms,
macroscopic observation, and MRI findings demonstrating
an area of low intensity on T1-weighted images and/or that
of high-intensity on T2-weighted images present within the
irradiation field after C-ion RT (Figure 1). Enhancement on
post-contrast images and diffusion-weighted images were
used to exclude the possibility of local recurrence. The
severity of ORN was assessed according to the Common
Terminology Criteria for Adverse Events version 4.0 as
follows: grade 1, asymptomatic with clinical or diagnostic
observations only and intervention not indicated; grade 2,
Figure 1 Representative magnetic resonance image (MRI) of the maxillary osteoradionecrosis. T1-weighted axial MRI showed low signal
appearance in the left maxilla (red arrows).
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living, and medical intervention indicated; grade 3, severe
symptoms, limiting self-care activities of daily living,
and selective surgical intervention indicated; grade 4,
life-threatening consequences with urgent intervention
indicated. The highest grade was used for analysis.Dose-volume histogram analysis
DVH analysis was performed to identify the dose-volume
effects on and risk factors for maxillary ORN. The maxillary
DVH included the alveolar process and palatine process of
the maxilla. However, the pterygoid process and maxillary
sinus were not included. Additionally, the root portion of
each tooth embedded in the maxilla was included, but its
crown was not (Figure 2). Cumulative DVH of the maxillaFigure 2 Representative contouring of the maxilla. All computed
tomography images of the contoured maxilla are shown.was calculated during treatment planning. Based on the
DVH data obtained from HIPLAN software, the maxilla
volumes receiving more than 10–50 GyE in 10-GyE incre-
ments were expressed as DVH parameters V10–50 (ml).
The average volume of the maxilla was 27.0 ml (range,
12.5–49.8 ml).Statistical analysis
The follow-up time was calculated from the first date of
irradiation. On univariate analysis of different subgroups,
cumulative incidence of maxillary ORN was evaluated
using the Kaplan–Meier method and compared by the
log-rank test. Furthermore, factors with statistical signifi-
cance on univariate analysis were applied to multivariate
analysis using Cox’s proportional hazard model. To com-
pare the irradiated maxilla volumes, the Mann-Whitney U
test was used. A p value of <0.05 was considered statistically
significant. All statistical analysis was performed using the
SPSS software version 11 (SPSS Inc., Chicago, IL).Results
Incidence of maxillary ORN
The median follow-up time was 79 months (range, 24–
167 months). Of the 63 enrolled patients, maxillary ORN
developed in 26 (41.3%). The median interval between
treatment initiation and maximum ORN observation was
23 months (range, 6–107 months). Grade 1 ORN was
observed in 14 patients; grade 2, in 9, and grade 3, in 3.
None of the patients experienced grade 4 ORN. The 3
patients with grade 3 ORN underwent sequestrectomy for
pain control. Subsequently, they also received implantation
of a denture and palatal prosthesis.
Table 2 Multivariate analysis of risk factors of
osteoradionecrosis
Hazard ratio 95% confidence interval p value
V50 1.15 1.06–1.25 0.0009
Teeth in the PTV 11.3 3.25–39.35 0.0001
V50 and the presence of teeth within the PTV were significant independent
risk factors for ORN.
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Univariate analysis was performed for clinical and DVH
parameters to analyze their effects on the development of
grade ≥1 ORN (Table 1). Patients were divided into 2
groups by median values for analysis of both age and DVH
parameters. On univariate analysis, large V10 to V50 values,
chemotherapy, and the presence of teeth within the PTV
were found to correlate with ORN development. However,
factors such as age, sex, smoking, and alcohol consumption
had no influence on ORN occurrence.
Multivariate analysis was performed with the factors
that reached statistical significance on univariate analysis:
V10 to V50 values, chemotherapy, and the presence of
teeth within the PTV. All data on DVH parameters were
evaluated as continuous variables, as opposed to discrete
cutoff points used in univariate analysis. Multivariate
analysis revealed that V50 (p = 0.0009; hazard ratio
[HR] = 1.15; 95% confidence interval [CI] = 1.06–1.25)
and the presence of teeth within the PTV (p = 0.0001;
HR = 11.3; 95% CI = 3.25–39.35) were significant inde-
pendent risk factors for ORN (Table 2).Table 1 Univariate analysis of risk factors of
osteoradionecrosis
Factors Subgroup n p value 5-y ORN rate (%)
V10 <14.5 ml 31 26.1
≥14.5 ml 32 0.015 53
V20 <11.9 ml 31 20
≥11.9 ml 32 0.001 58.5
V30 <8.1 ml 31 13.7
≥8.1 ml 32 0.001 64.4
V40 <4.6 ml 31 12.1
≥4.6 ml 32 0.0002 67.7
V50 <3.0 ml 31 11.7
≥3.0 ml 32 0.0002 69.5
Age (years) <59 31 33.5
≥59 32 0.23 45.5
Sex Male 31 40.4
Female 32 0.5 38.2
Teeth in the PTV None 34 5.9
Some 29 0.0001 81
Smoking Yes 22 41.6
No 41 0.66 38.6
Alcohol Yes 31 48.6
No 32 0.11 30.3
Chemotherapy Yes 23 54.0
No 40 0.04 30.5
A large V10 to V50 and the presence of teeth within the PTV were found to
correlate with ORN development.Correlation between DVH parameters and ORN
Figure 3 shows the mean percentages of DVH parameters
from V10 to V50 in patients with and without ORN. All
DVH parameters were significantly higher in patients with
ORN than in those without ORN (Table 3).
Discussion
ORN of the maxilla is a serious adverse event in patients
receiving C-ion RT for head and neck tumors. Therefore,
it is clinically important to define the risk factors for
ORN. In the present study, we demonstrated that ORN
development after C-ion RT correlated with dosimetric
parameters. In addition, our results confirmed that
V50 and the presence of teeth within the PTV were
independent risk factors for ORN.
Several previous studies have reported the effects of dosi-
metric parameters on ORN prediction [4,6-8]. Tsai et al. [6]
reviewed 402 oropharyngeal cancer patients treated with
definitive photon RT using three-dimensional conformal
radiotherapy or intensity modulated radiotherapy for ORN
and revealed that V40, V50, and V60 were risk factors for
ORN on univariate analysis, whereas V50 and V60 were
also risk factors on multivariate analysis. On the basis of
such findings, they concluded that minimizing the percent-
age of bone volume exposed to 50 Gy could reduce ORN
risk. In our study, although a 16-fraction protocol was used
for C-ion RT, V50 remained a statistically significant inde-
pendent risk factor for ORN. If the predetermined RBE
value was correct, and the linear-quadratic model could be
applied to C-ion RT, 50 GyE in 16 fractions would be
equivalent to 61.1 GyE at a standard fractionation of 2 GyE
per fraction with a 3-Gy α/β value.
Chang et al. [7] reported that a radiation dose of more
than 70 Gy was associated with an increased risk for
ORN. Ben-David et al. [4] and Studer et al. [8] suggested
that ORN might be related to mandibular volumes
receiving high doses as the situation could exacerbate
bone exposure caused by severe acute mucositis. Therefore,
a reduction of the bone volume exposed to a high radiation
dose may prevent ORN. When comparing the DVH
parameters between patients with ORN and those without,
a significant difference was observed even at lower radi-
ation doses. However, the effects of low radiation dose on
the occurrence of ORN remain unclear. In the above-
mentioned study by Tsai et al. [6], V10 to V30 were
not risk factors for ORN on univariate analysis. In
Figure 3 The average maxillary volumes receiving 10 to 50 GyE according to the occurrence of osteoradionecrosis. All DVH parameters
were significantly higher in patients with ORN than in those without.
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V10 to V30 were risk factors for ORN on univariate
analysis, although only V50 was confirmed as a risk
factor by multivariate analysis. The difference between
C-ion RT and photon RT data for low doses might
result from dose distribution features of these modal-
ities. In three-dimensional conformal radiotherapy and
intensity modulated radiotherapy, low-dose regions
are generally enlarged because multi-portals are used
to ensure conformable dose distribution to the target.
On the other hand, C-ion RT can deliver conformable
dose distribution to the target without expanding the
low-dose regions [13]. Therefore, the maxilla volumes
irradiated at low doses in C-ion RT might actually
correlate with those receiving higher doses.
In our study, the presence of teeth within the PTV
was indicated as an independent risk factor for ORN
after C-ion RT. The correlation between the presence of
teeth within the PTV and ORN in photon RT has also
been reported. Morrish et al. [14] reported that ORN
developed in 19 of 78 (24.4%) patients with in-field teeth,
whereas only 3 of 22 (13.6%) patients without in-field
teeth experienced the condition. Additionally, Chang et al.
[7] reported that the rate of ORN for patients with in-fieldTable 3 Correlation between dose-volume histogram
parameters and osteoradionecrosis
Parameters (mean, ml) ORN No ORN p value
V10 20.68 13.71 0.0054
V20 16.55 9.64 0.0004
V30 13.34 5.86 <0.0001
V40 10.90 3.73 <0.0001
V50 9.32 2.48 <0.0001
All DVH parameters were significantly higher in patients with ORN than in
those without ORN.teeth was 32/239 (13.4%), while it was only 5/174 (2.9%)
for those without in-field teeth. ORN has been suggested
to develop as a result of gingiva regression by irradiation,
leading to an environment that is susceptible to bone
infection [15]. In fact, ORN development was found
around the tooth in several patients after C-ion RT. Thus,
oral care after treatment is very important, especially in
cases when teeth are included in the PTV.
Most available reports on ORN after photon RT to
head and neck tumors have focused on the mandible. In
the present study, we instead investigated ORN of the
maxilla because tumors treated with C-ion RT were
primarily located in the sinonasal cavity. However, our
results on ORN of the maxilla were similar to previous
findings on the mandible. Although the mandible is also
irradiated in C-ion RT for sinonasal tumors, the radiation
dose delivered to the mandible could be reduced owing to
its superior physical spatial distribution.
In our study, ORN was observed on the basis of MRI
findings in 26 of 63 patients (41.3%) during a median
follow-up time of 79 months. Owing to the sensitivity of
MRI, 14 of the 26 patients were diagnosed with grade 1
ORN and exhibited no clinical symptoms. Grade 3 ORN
was observed in only 3 patients.
Since the present study aimed to investigate the effects
of irradiation on ORN development in patients treated
with C-ion RT, patients with tumor invasion to the
maxilla before C-ion RT were excluded, as it may be
challenging to distinguish between osteomyelitis caused
by tumor invasion and ORN.
Conclusion
Our findings from the present study are useful for
predicting the risk of ORN and therefore preventing
the development of such a condition after C-ion RT for
head and neck tumors. We found that ORN development
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In addition, V50 and the presence of teeth within the PTV
were risk factors for the development of ORN after C-ion
RT. Such findings confirmed the dose-volume effects on
ORN development.
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